RGSFX | RGWEX | RGSFX / RGWEX | |
Total Expense Ratio | 0.52 | 0.71 | 73% |
Annual Report Gross Expense Ratio | 0.52 | 0.71 | 73% |
Fund Existence | 10 years | 13 years | - |
Gain YTD | 16.384 | 16.246 | 101% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 24.2B | 24.2B | 100% |
Annual Yield % from dividends | 0.57 | 0.41 | 140% |
Returns for 1 year | 11.61 | 11.41 | 102% |
Returns for 3 years | 63.02 | 62.43 | 101% |
Returns for 5 years | 47.42 | 46.62 | 102% |
Returns for 10 years | N/A | 111.05 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PJP | 91.08 | 0.87 | +0.96% |
Invesco Pharmaceuticals ETF | |||
FFEB | 54.93 | 0.17 | +0.32% |
FT Vest US Equity Buffer ETF Feb | |||
NUAG | 21.27 | 0.02 | +0.12% |
Nuveen Enhanced Yield US Aggt Bd ETF | |||
KPDD | 25.72 | -0.47 | -1.79% |
KraneShares 2x Long PDD Daily ETF | |||
RXD | 11.91 | -0.24 | -2.00% |
ProShares UltraShort Health Care |